Male Fertility Male Factor Treatment

A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia

Lenzi A, Sgrò P, Salacone P, Paoli D, Gilio B, Lombardo F, Santulli M, Agarwal A, Gandini L

Published June 15, 2004 Fertility and Sterility, 81(6), 1578-1584
DOI 10.1016/j.fertnstert.2003.10.034 PMID 15193480

RRM Academy Synopsis

Carnitine raised motile sperm numbers more than placebo in 56 men

Carnitine raised the number of moving sperm per ejaculate more than placebo in 56 infertile men with weak sperm motility. The percentage of moving sperm did not differ significantly between groups. The trial was randomized and double-blind. Four partners became pregnant, all in the carnitine group.

Key Findings

  • Sixty infertile men aged 20 to 40 with reduced sperm motility were randomized, 30 to carnitine and 30 to placebo. All 30 carnitine men and 26 of 30 placebo men finished.
  • Percentages of total and forward-moving sperm rose more with carnitine, and the differences between the groups were not statistically significant.
  • Total motile sperm per ejaculate rose significantly more with carnitine in the whole group (P = .042). Forward motile sperm per ejaculate also rose more (P = .044).
  • Among men with the lowest starting motile sperm numbers, carnitine gains were larger: total motile sperm (P = .038) and forward motile sperm (P = .043).
  • Four partners became pregnant, all four men in the carnitine group, in months 4, 5 and 6 of treatment. None of the four showed a significant change in forward motility.

Interpretation

This randomized, double-blind trial compared carnitine with placebo in men with low sperm motility. Carnitine raised total and forward motile sperm counts per ejaculate across the whole group, with the largest gains in men who started with the lowest motile sperm counts. Sperm measures also rose in the placebo group; the authors attribute part of that rise to regression to the mean. Four pregnancies occurred during treatment, all in the carnitine group. The findings support larger studies of carnitine for men with low sperm motility.

RRM Context

Restorative reproductive medicine looks for the cause in both partners. Doctors found no cause in the female partners. They also ruled out the other common causes of low sperm motility in the men.

Abstract

Objective

To determine the efficacy of combined l-carnitine and l-acetyl-carnitine therapy in infertile males with oligo-astheno-teratozoospermia.

Design

Placebo-controlled double-blind randomized trial.

Setting

University tertiary referral center.

Patients

Sixty infertile patients (aged 20-40 years) with the following baseline sperm selection criteria: concentration, 10 to 40 x 10(6)/mL; forward motility, <15%; total motility, 10% to 40%; and atypical forms, <80%. Fifty-six patients completed the study.

Interventions

Patients were submitted to a combined treatment of l-carnitine (2 g/d) and l-acetyl-carnitine (1 g/d) or of placebo; the study design was 2 months' wash-out, 6 months of therapy or of placebo, and 2 months' follow-up.

Main Outcome Measures

Variation in the semen parameters that were used for patient selection.

Results

Even though increases were seen in all sperm parameters after combined carnitine treatment, the most significant improvement in sperm motility (both forward and total) was present in patients who had lower initial absolute values of motile sperm (<4 x 10(6) forward or <5 x 10(6) total motile spermatozoa per ejaculate).

Conclusions

Combined treatment with l-carnitine and l-acetyl-carnitine in a controlled study of efficacy was effective in increasing sperm motility, especially in groups with lower baseline levels.

Topics

By this author

Related research

Male Fertility › Male Factor Treatment › Medical Management
Andrea Lenzi, Paolo Sgrò, Pietro Salacone, Donatella Paoli, Barbara Gilio, Francesco Lombardo, Maria Santulli, Ashok Agarwal, Loredana Gandini
A Lenzi, P Sgrò, P Salacone, D Paoli, Barb Gilio, B Gilio, F Lombardo, M Santulli, A Agarwal, L Gandini
PMID 15193480 15193480 DOI 10.1016/j.fertnstert.2003.10.034 10.1016/j.fertnstert.2003.10.034 Lenzi et al. 2004, Lenzi 2004